top of page
OA Hero 1 advocacy v4 Screens FINAL.jpg

Theranostics Across Different Cancer Types

Theranostics is already helping transform care for selected patients with several cancer types and continues to be explored across a growing range of diseases.

Discover Where Theranostics Is Making a Difference

While its role varies depending on the cancer type, theranostics combines advanced diagnostic imaging with targeted radionuclide therapies to support more personalised approaches to patient care.

This page provides an overview of where theranostics is currently being used, where research is ongoing and where you can find trusted information about specific cancers.

If you have questions about your individual circumstances, treatment options or eligibility for theranostic approaches, please speak with your healthcare team.

Theranostic and targeted radionuclide approaches are established or available across several cancers, including prostate cancer, neuroendocrine tumours, thyroid cancer and selected non-melanoma skin cancers, with the nature and maturity of these approaches varying by cancer type.

Prostate Cancer

Prostate cancer is currently one of the most established areas for theranostics.

Explore >>

Neuroendocrine Tumours

Theranostics has become an important treatment pathway for selected patients with neuroendocrine tumours.

Explore >>

Thyroid Cancer

Theranostic principles have been used in thyroid cancer management for many years through radioactive iodine imaging and treatment approaches.

Explore >>

Skin Cancer

Theranostic approaches are increasingly being explored and utilised in the management of selected non-melanoma skin cancers.

Explore >>

Emerging Areas of Research

While some approaches remain investigational, ongoing clinical studies continue to expand understanding of where theranostics may contribute to future patient care.

Researchers are currently investigating the potential role of theranostics across a growing range of cancers, including:

  • Breast cancer

  • Lung cancer

  • Brain cancer

  • Ovarian cancer

  • Pancreatic cancer

  • Colorectal cancer

  • Melanoma

  • Multiple myeloma

Frequently Asked Questions

Continue Exploring

Frequently Asked Questions

Explore answers to some of the most common questions about theranostics, precision medicine and targeted cancer care.​

Discover Now

What is Theranostics?

Discover how theranostics is changing the future of personalised healthcare.​

Explore Now

Patient Support

Find practical information and support for every stage of your journey.​

Let's Go

Healthcare Professionals

Explore clinical insights, research developments and collaboration opportunities shaping the future of theranostics.​

Go to HCP Section

Medical Disclaimer
The information provided on this website is intended for educational purposes only and should not be considered medical advice. Treatment decisions should always be made in consultation with qualified healthcare professionals who can consider individual circumstances and clinical needs.

Oncothera ICON white

Oncothera Advocacy is the Voice for Theranostics

Support Us

Quick Links

Small Print

Privacy Policy

Disclaimer

Site developed by
 Showoff Group.

ACNC registration logo

Oncothera Advocacy is a Registered Charity with the Australian Charities and Not–for–profit Commission.

Acknowledgement of Country

Oncothera Advocacy acknowledges Aboriginal and Torres Strait Islander peoples as the Traditional Custodians of the lands on which we live, work and connect. We pay our respects to Elders past and present, and recognise their continuing connection to land, waters, culture and community.

Commitment to Inclusion

Oncothera Advocacy is committed to an inclusive healthcare community where everyone is treated with dignity, respect and equity. We welcome and support people of all backgrounds, cultures, identities, genders and sexual orientations, including LGBTQIA+ communities.

bottom of page